A detailed history of Kingsview Wealth Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Kingsview Wealth Management, LLC holds 345,225 shares of MRK stock, worth $33.8 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares
345,225
Previous 289,784 19.13%
Holding current value
$33.8 Million
Previous $35.9 Million 9.28%
% of portfolio
0.88%
Previous 0.9%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$111.15 - $128.97 $6.16 Million - $7.15 Million
55,441 Added 19.13%
345,225 $39.2 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $2.88 Million - $3.09 Million
23,241 Added 8.72%
289,784 $35.9 Million
Q1 2024

May 09, 2024

BUY
$113.24 - $131.95 $2.95 Million - $3.43 Million
26,020 Added 10.82%
266,543 $35.2 Million
Q4 2023

Feb 08, 2024

BUY
$100.18 - $109.02 $15.7 Million - $17.1 Million
156,563 Added 186.47%
240,523 $26.2 Million
Q3 2023

Nov 07, 2023

BUY
$102.95 - $114.33 $1.22 Million - $1.35 Million
11,814 Added 16.38%
83,960 $8.64 Million
Q2 2023

Aug 10, 2023

SELL
$108.61 - $118.38 $775,149 - $844,878
-7,137 Reduced 9.0%
72,146 $8.32 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $1.45 Million - $1.62 Million
-14,090 Reduced 15.09%
79,283 $8.43 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $257,860 - $330,612
-2,949 Reduced 3.06%
93,373 $10.4 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $1.39 Million - $1.57 Million
16,490 Added 20.66%
96,322 $8.3 Million
Q2 2022

Aug 16, 2022

BUY
$83.49 - $94.64 $1.62 Million - $1.84 Million
19,424 Added 32.15%
79,832 $7.28 Million
Q1 2022

Feb 08, 2024

SELL
$73.51 - $82.4 $13.1 Million - $14.7 Million
-178,524 Reduced 74.22%
61,999 $5.09 Million
Q4 2021

Feb 17, 2022

BUY
$72.28 - $90.54 $70,111 - $87,823
970 Added 1.63%
60,408 $4.63 Million
Q3 2021

Dec 03, 2021

BUY
$71.68 - $78.83 $4,300 - $4,729
60 Added 0.1%
59,438 $4.46 Million
Q2 2021

Aug 17, 2021

BUY
$70.31 - $77.77 $173,876 - $192,325
2,473 Added 4.35%
59,378 $4.63 Million
Q1 2021

May 24, 2021

BUY
$68.86 - $81.11 $37,528 - $44,204
545 Added 0.97%
56,905 $4.39 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $134,999 - $149,821
1,881 Added 3.45%
56,360 $4.61 Million
Q3 2020

Nov 19, 2020

BUY
$73.18 - $82.95 $44,932 - $50,931
614 Added 1.14%
54,479 $4.52 Million
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $1.81 Million - $2.06 Million
25,759 Added 91.65%
53,865 $4.17 Million
Q1 2020

May 11, 2020

BUY
$63.36 - $87.82 $421,534 - $584,266
6,653 Added 31.01%
28,106 $2.16 Million
Q4 2019

Jan 31, 2020

BUY
$77.58 - $87.54 $972,930 - $1.1 Million
12,541 Added 140.72%
21,453 $1.95 Million
Q4 2019

Jan 30, 2020

SELL
$77.58 - $87.54 $584,410 - $659,438
-7,533 Reduced 45.81%
8,912 $501,000
Q3 2019

Jan 29, 2020

BUY
$76.08 - $82.93 $67,406 - $73,475
886 Added 5.69%
16,445 $1.38 Million
Q2 2019

Jan 29, 2020

BUY
$69.84 - $81.59 $63,484 - $74,165
909 Added 6.2%
15,559 $1.31 Million
Q1 2019

Jan 29, 2020

SELL
$69.58 - $79.36 $2.67 Million - $3.04 Million
-38,366 Reduced 72.37%
14,650 $1.22 Million
Q4 2018

Jan 29, 2020

BUY
$65.24 - $75.71 $44,232 - $51,331
678 Added 1.3%
53,016 $4.05 Million
Q3 2018

Jan 29, 2020

BUY
$57.69 - $67.84 $98,822 - $116,209
1,713 Added 3.38%
52,338 $3.71 Million
Q2 2018

Jan 29, 2020

BUY
$50.83 - $59.72 $35,835 - $42,102
705 Added 1.41%
50,625 $3.07 Million
Q1 2018

Jan 29, 2020

BUY
$50.96 - $59.23 $2.09 Million - $2.43 Million
41,008 Added 460.14%
49,920 $2.72 Million
Q4 2017

Jan 29, 2020

SELL
$51.62 - $61.64 $42,947 - $51,284
-832 Reduced 8.54%
8,912 $501,000
Q3 2017

Jan 29, 2020

BUY
$58.67 - $63.13 $63,950 - $68,811
1,090 Added 12.6%
9,744 $624,000
Q2 2017

Jan 29, 2020

BUY
N/A
1,063 Added 14.0%
8,654 $555,000
Q1 2017

Jan 29, 2020

BUY
N/A
7,591
7,591 $482,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Kingsview Wealth Management, LLC Portfolio

Follow Kingsview Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.